
The diagnosis and treatment of zzso cell lung cancer zzso have been revolutionized over the last few zzso zzso for zzso in lung cancer diagnosis have therefore zzso The general diagnostic category of zzso is no longer zzso In addition zzso specimens need to be evaluated for zzso regarding zzso marker zzso zzso zzso zzso with a distinction of zzso from zzso cell zzso is crucial for treatment decisions as the zzso will decide on the chemotherapy regimen and the choice of zzso marker analyses for targeted zzso In the majority of cases, the zzso can be diagnosed by zzso zzso zzso is equally well suited as biopsy specimens for the assessment of molecular zzso zzso The best results are achieved when both zzso and biopsy specimens are compared to choose the most appropriate zzso for zzso zzso and molecular zzso In this paper, we discuss special issues of zzso zzso and currently recommended zzso molecular marker zzso 

